IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

RepositoryUniversity of Queensland [UQ eSpace]
URL
Author(s)Stewart, A.; Roberts, J. A.; Wallis, S. C.; Allworth, A. M.; Legg, A.; McCarthy, K. L.
Item typeArticle
JournalInternational Journal of Antimicrobial Agents, Print_ISSN:0924-8579
DOIhttps://doi.org/10.1016/j.ijantimicag.2018.02.008

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Country Reporting Period Total 2021-12-05 2021-12-06 2021-12-07 2021-12-08 2021-12-09 2021-12-10 2021-12-11 2021-12-12 2021-12-13 2021-12-14 2021-12-15 2021-12-16
Overall totals 4 1 0 0 0 0 0 1 0 0 0 1 1
United States 4 1 0 0 0 0 0 1 0 0 0 1 1
Jisc logo Cranfield logo CAVAL logo